WallStreetZenWallStreetZen

NASDAQ: SABS
Sab Biotherapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SABS

Based on 2 analysts offering 12 month price targets for Sab Biotherapeutics Inc.
Min Forecast
$3.00+240.91%
Avg Forecast
$3.50+297.73%
Max Forecast
$4.00+354.55%

Should I buy or sell SABS stock?

Based on 2 analysts offering ratings for Sab Biotherapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SABS stock forecasts and price targets.

SABS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 5%
96
BuyReiterates$4.00+354.55%2023-05-17
Chardan Capital
Top 4%
97
Strong BuyReiterates$3.00+240.91%2023-04-27

1 of 1

Forecast return on equity

Is SABS forecast to generate an efficient return?
Company
N/A
Industry
0.08%
Market
72.92%

Forecast return on assets

Is SABS forecast to generate an efficient return on assets?
Company
N/A
Industry
0.1%

SABS revenue growth forecast

How is SABS forecast to perform vs Biotechnology companies and vs the US market?
Company
71.02%
Industry
39.75%
Market
8.34%
SABS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SABS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SABS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SABS$0.88$3.50+297.73%Strong Buy
NCNA$0.85$4.00+370.59%Buy
SNSE$1.43$6.00+321.05%Strong Buy
TSHA$0.70$4.86+594.86%Buy
COYA$4.37$17.33+296.64%Strong Buy
View Top Biotech Stocks

Sab Biotherapeutics Stock Forecast FAQ

Is Sab Biotherapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: SABS) stock is to Strong Buy SABS stock.

Out of 2 analysts, 1 (50%) are recommending SABS as a Strong Buy, 1 (50%) are recommending SABS as a Buy, 0 (0%) are recommending SABS as a Hold, 0 (0%) are recommending SABS as a Sell, and 0 (0%) are recommending SABS as a Strong Sell.

If you're new to stock investing, here's how to buy Sab Biotherapeutics stock.

What is SABS's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: SABS) forecast ROE is N/A, which is considered weak.

What is SABS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SABS price target, the average SABS price target is $3.50, with the highest SABS stock price forecast at $4.00 and the lowest SABS stock price forecast at $3.00.

On average, Wall Street analysts predict that Sab Biotherapeutics's share price could reach $3.50 by May 17, 2024. The average Sab Biotherapeutics stock price prediction forecasts a potential upside of 297.73% from the current SABS share price of $0.88.

What is SABS's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: SABS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.1%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.